We are live on ! Find out more
PHXM

PHAXIAM Therapeutics S.A.. American Depositary Shares
PHXM

Delisted

PHXM was delisted on the 8th of March, 2024.

Back to rankings

3 hedge funds and large institutions have $7.66M invested in PHAXIAM Therapeutics S.A.. American Depositary Shares in 2020 Q3 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 0 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

25% less funds holding

Funds holding: 4 → 3 (-1)

33% less capital invested

Capital invested by funds: $11.4M → $7.66M (-$3.72M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
3
Holders Change
-1
Holders Change %
-25%
% of All Funds
0.06%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
PF
Phoenix Financial
Israel
-$267K
Name Holding Trade Value Shares
Change 		Change in
Stake
BI
1
BVF Inc
California
$3.91M – – –
NMC
2
NEA Management Company
Maryland
$3.75M – – –
Millennium Management
3
Millennium Management
New York
$96 – – –
PF
4
Phoenix Financial
Israel
– -$267K -3,295 Closed

PHXM Hedge Fund Activity: Q3 2020 in Review

3 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in PHAXIAM Therapeutics S.A.. American Depositary Shares (PHXM) for Q3 2020, worth a combined $7.66M — down 33% from $11.4M a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of PHXM and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

The largest seller was Phoenix Financial, exiting entirely with an estimated $267K sold.

  • 3 institutional investors held PHAXIAM Therapeutics S.A.. American Depositary Shares (PHXM) as of Q3 2020, down from 4 in Q2 2020.
  • Funds reported $7.66M of PHAXIAM Therapeutics S.A.. American Depositary Shares stock for Q3 2020, down 33% quarter-over-quarter.
  • 0 funds opened new PHAXIAM Therapeutics S.A.. American Depositary Shares positions in Q3 2020 and 1 closed out, a net change of -1 holder.
  • The largest PHAXIAM Therapeutics S.A.. American Depositary Shares seller in Q3 2020 was Phoenix Financial, an estimated $267K sold.

Based on aggregated 13F filings for Q3 2020.